Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Absztrakt
Leírás
Kulcsszavak
Forrás
Haematologica. -102 : 5 (2017), p. 903-909. -Haematologica. - 0390-6078